Notch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas

Jian Liu1, Huijie Fan, Yuanyuan Ma

  • 1Department of Pathology, The First Teaching Hospital of Zhengzhou University, Basic Medical College, Zhengzhou University, Zhengzhou, Henan Province, China.

Plos One
|February 15, 2013
PubMed

Insights

Notch1 expression in esophageal squamous cell carcinoma is linked to increased aggressiveness and resistance to 5-FU chemotherapy. Higher Notch1 levels correlate with poor patient survival, highlighting its role in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Notch signaling is crucial for normal cell functions, including stem cell maintenance.
  • Its role in cancer stem cells suggests involvement in oncogenesis.
  • Esophageal squamous cell carcinoma (ESCC) is a significant global health concern.

Purpose of the Study:

  • To investigate the expression and role of Notch family members, particularly Notch1, in ESCC.
  • To determine the correlation between Notch1 expression, tumor differentiation, drug resistance, and patient survival.

Main Methods:

  • Quantitative RT-PCR to assess Notch gene expression in ESCC cell lines and a control cell line.
  • Western blot analysis to evaluate Notch1 protein levels.
  • Hypoxia induction experiments.
  • 5-Fluorouracil (5-FU) resistance assays.
  • Notch1 knockdown experiments.
  • Immunohistochemical analysis of Notch1 in clinical ESCC samples.

Main Results:

  • Higher Notch1 and Notch3 expression was observed in ESCC cell lines compared to normal esophageal epithelial cells.
  • Poorly differentiated KYSE70 cells showed high, hypoxia-inducible Notch1 expression, while well-differentiated KYSE450 cells were negative for Notch1.
  • KYSE70 cells exhibited greater 5-FU resistance, which was linked to Notch1 expression.
  • Clinical ESCC samples showed Notch1 expression associated with higher pathological grade and shorter overall survival.

Conclusions:

  • Notch1 expression is associated with increased cell aggressiveness and 5-FU drug resistance in ESCC cell lines.
  • Notch1 is a potential biomarker for poor prognosis in patients with esophageal squamous cell carcinoma.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...